Latest Whitepapers

Tissue dissociation is a crucial sample preparation step that enables the isolation of specific cell populations for downstream applications such as single-cell RNA sequencing. Enzymatic tissue dissociation is widely used, but some researchers have concerns about the impact of enzymes on cell marker expression.

mRNA-based therapies, from infectious disease vaccines to genetic disorder treatments, are gaining traction. However, mRNA purification methods must evolve beyond traditional precipitation techniques to meet the demands of large-scale therapeutic production.

As researchers endeavor to map the architecture of the brain, many rely on tissue dissociation approaches to prepare single-cell suspensions for downstream analysis. Howev er, such conventional methods can involve enzymes and heat, which are known to induce transcriptional and proteotype changes in brain cells.

This whitepaper explores the latest reagents and software available to enhance tumor exome profiling for the generation of accurate, actionable clinical insights.

For a smooth molecule journey from benchtop to clinic you need to make the most informed candidate selection and reduce the risk of failure and complications during development. Our BiacoreTM systems support informed decision-making during the lead candidate selection process. Its technology delivers valuable insights into developability such as manufacturability and safety.

This whitepaper explores how scientists can identify and take advantage of untapped business value in existing lab data.

This whitepaper highlights the latest innovations and technologies that can secure the future of LIBs in the alternative energy revolution.

This whitepaper highlights a variety of sustainable food solutions and analytical innovations that can help new products break through to consumer markets.

While the industry was put front and center during the COVID-19 pandemic, diagnostics have always been critical in treating illnesses and managing health. Technological advances, innovative platforms, and decentralized test options are driving exciting developments and optimism across the diagnostics industry.

This whitepaper highlights common challenges in gene therapy development and explores the latest analytical approaches available to combat workflow disruption.